EMBO Mol Med 13:e13067
Limited safety data: Long-term human safety data is limited
K.SharmaN
Its natural origin, ability to cross the blood-brain barrier, and multi-modal mechanismsimpacting oxidative stress, mitochondrial dysfunction, and immune dysregulationmake it a promising candidate for integrative treatment approaches
In support of this, treatment of cytosolic extracts from mouse WAT and BAT with desnutrin/ATGL antibodies decreased FA release by approximately two-thirds (144)
With inputs from Dr Mohan Thomas, cosmetic surgeon, Cosmetic Surgery And Skin Institute, Mumbai and Pune, Dr Saumya Shetty Hegde, cosmetologist, Roots Skin Clinic, Chembur and Dr Shuba Dharmana, dermatologist, Lejeune Medspa, Bangalore